CDMRP Tick-Borne Disease Research program: Therapeutic/Diagnostic Research Award

The Therapeutic/Diagnostic Research Award is intended to support hypothesis-driven therapeutic and diagnostic development research. The proposed studies are expected to be empirical in nature and product-driven.

Therapeutic/Diagnostic Research Award applications must respond to at least one of the following specific FY24 TBDRP Therapeutic/Diagnostic Research Award Focus Areas:

• Treatment :
- Evaluation of novel therapeutics or repurposed compounds for treatment of tick-borne diseases
- Extensive refinement of therapeutic candidates in a drug development program, including but not limited to studies of structure/activity relationships, and pharmacokinetic/pharmacodynamic and toxicologic studies

• Diagnosis:
- Evaluation/validation of approaches that provide diagnostic advantages for single or multiple tick-borne pathogens, with priority given to direct detection or multiplex assays

- Evaluation/validation of more accurate or novel approaches capable of distinguishing active Lyme disease infection from previous exposure and/or resolution of infection

- Evaluation/validation of approaches for the detection/diagnosis of maternal-to-fetal transmission of Lyme disease and/or other tick-borne infections

It is expected that 2 T/DR awards will be granted.

Funding: $830,000 total

Duration: 3 years 

Research Authority due date: 19.6.24

Pre application (required) due date: 26.6.24

Full proposal due date: 3.10.24